GAMMA Investing’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$127K Buy
1,337
+118
+10% +$9.7K ﹤0.01% 1678
2026
Q2
$99.4K Buy
1,219
+42
+4% +$2.95K ﹤0.01% 1811
2026
Q1
$67.1K Buy
1,177
+1
+0.1% +$58 ﹤0.01% 1965
2025
Q4
$59.5K Buy
1,176
+24
+2% +$1.23K ﹤0.01% 1953
2025
Q3
$57.6K Sell
1,152
-9
-0.8% -$412 ﹤0.01% 1890
2025
Q2
$46.5K Buy
1,161
+235
+25% +$8.76K ﹤0.01% 1982
2025
Q1
$32.4K Buy
926
+661
+249% +$26.1K ﹤0.01% 2099
2024
Q4
$10.4K Sell
265
-77
-23% -$2.77K ﹤0.01% 2597
2024
Q3
$10K Buy
342
+163
+91% +$4.97K ﹤0.01% 2461
2024
Q2
$5.53K Buy
179
+105
+142% +$3.33K ﹤0.01% 2535
2024
Q1
$2.65K Buy
74
+40
+118% +$1.44K ﹤0.01% 2658
2023
Q4
$1.23K Buy
+34
New +$1.1K ﹤0.01% 2739

Other funds holding PRLB

GAMMA Investing's PRLB Position: Q3 2026 in Review

GAMMA Investing increased its Protolabs (PRLB) stake by 9.7% in Q3 2026, buying an estimated $9.7K and bringing the position to 1,337 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1678.

GAMMA Investing first reported a position in PRLB in Q4 2023 and has held it in 12 quarters since. 6 funds tracked by Wall St. Rank hold PRLB as of Q3 2026.

  • GAMMA Investing held 1,337 shares of Protolabs worth $127K as of Q3 2026.
  • GAMMA Investing bought 118 Protolabs shares in Q3 2026, an estimated $9.7K.
  • Protolabs made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1678 holding.
  • GAMMA Investing first reported a position in Protolabs in Q4 2023 and has held it in 12 quarters since.
  • 6 funds tracked by Wall St. Rank held Protolabs as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.